| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5685326 | American Journal of Kidney Diseases | 2017 | 9 Pages |
Abstract
The cost-effectiveness of vascular access referral is largely driven by the annual costs of HD, erythropoietin costs, and access-specific utilities. Further research is needed in the field of dialysis-related quality of life to inform decision making regarding vascular access referral.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Steven M. PhD, Talon BASc, M. Reza PhD, Nadia MD, SM,